Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
BMC Infect Dis ; 17(1): 150, 2017 02 16.
Artigo em Inglês | MEDLINE | ID: mdl-28209132

RESUMO

BACKGROUND: Urinary Tract Infection (UTI) causes a serious health problem and affects millions of people worldwide. Patients with obstetric fistula usually suffer from incontinence of urine and stool, which can predispose them to frequent infections of the urinary tract. Therefore the aim of this study was to determine the etiologic agents, drug resistance pattern of the isolates and associated risk factor for urinary tract infection among fistula patients in Addis Ababa fistula hospital, Ethiopia. METHODS: Across sectional study was conducted from February to May 2015 at Hamlin Fistula Hospital, Addis Ababa, Ethiopia. Socio-demographic characteristics and other UTI related risk factors were collected from study participants using structured questionnaires. The mid-stream urine was collected and cultured on Cysteine lactose electrolyte deficient agar and blood agar. Antimicrobial susceptibility was done by using disc diffusion method and interpreted according to Clinical and Laboratory Standards Institute (CLSI). Data was entered and analyzed by using SPSS version 20. RESULTS: Out of 210 fistula patients investigated 169(80.5%) of the patient were younger than 25 years. Significant bacteriuria was observed in 122/210(58.1%) and 68(55.7%) of the isolates were from symptomatic cases. E.coli 65(53.7%) were the most common bacterial pathogen isolated followed by Proteus spp. 31(25.4%). Statistical Significant difference was observed with history of previous UTI (P = 0.031) and history of catheterization (P = 0.001). Gram negative bacteria isolates showed high level of resistance (>50%) to gentamicin and ciprofloxacin, while all gram positive bacteria isolated were showed low level of resistance (20-40%) to most of antibiotic tested. CONCLUSIONS: The overall prevalence of urinary tract infection among fistula patient is 58.1%. This study showed that the predominant pathogen of UTI were E.coli followed by Proteus spp. It also showed that amoxicillin-clavulanic acid was a drug of choice for urinary tract bacterial pathogens.


Assuntos
Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Antibacterianos/uso terapêutico , Incontinência Fecal/complicações , Fístula Retovaginal/complicações , Incontinência Urinária/complicações , Infecções Urinárias/etiologia , Adolescente , Adulto , Bacteriúria/epidemiologia , Criança , Etiópia/epidemiologia , Feminino , Bactérias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/isolamento & purificação , Humanos , Masculino , Testes de Sensibilidade Microbiana , Gravidez , Prevalência , Fístula Retovaginal/epidemiologia , Fístula Retovaginal/microbiologia , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia , Adulto Jovem
3.
J Obstet Gynaecol Res ; 40(4): 1141-4, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24428845

RESUMO

Rectovaginal fistula formation secondary to Bartholin's cyst is a very rare complication, and to date only three cases were reported in the literature. We report a case of a 32-year-old woman who suffered recurrent episodes of Bartholin's cyst infection with subsequent abscess formation that resulted in rectovaginal fistula formation. We treated her initially with transperineal repair; however, the fistulous tract recurred a month later. A laparoscopic colostomy and transperineal repair using biological graft was then performed, with excellent results. The patient underwent reversal of colostomy after 2 months, and remained asymptomatic upon follow-up 12 months later.


Assuntos
Glândulas Vestibulares Maiores/microbiologia , Cistos/fisiopatologia , Fístula Retovaginal/cirurgia , Infecções do Sistema Genital/fisiopatologia , Doenças da Vulva/fisiopatologia , Adulto , Antibacterianos/uso terapêutico , Materiais Biocompatíveis/uso terapêutico , Colágeno/uso terapêutico , Cistos/tratamento farmacológico , Cistos/microbiologia , Enterobacteriaceae/crescimento & desenvolvimento , Enterobacteriaceae/isolamento & purificação , Feminino , Humanos , Dor Pélvica/etiologia , Fístula Retovaginal/etiologia , Fístula Retovaginal/microbiologia , Fístula Retovaginal/fisiopatologia , Recidiva , Reoperação , Infecções do Sistema Genital/tratamento farmacológico , Infecções do Sistema Genital/microbiologia , Resultado do Tratamento , Doenças da Vulva/tratamento farmacológico , Doenças da Vulva/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...